Drilldown: Medicines
Appearance
Use the filters below to narrow your results.
2C-x series (1) ·
Dissociative (1) ·
Phenethylamine (1) ·
Psychedelic (1) ·
Research material (1) ·
secondary amine)]] (1) ·
[[:Category:Antidepressants|Antidepressant]] (1) ·
[[:Category:Migraine prophylactics|Migraine prophylactic]] (1) ·
[[:Category:Neuropathic pain medicines|Neuropathic pain medicine]] (1) ·
[[:Category:Tricyclic antidepressants|Tricyclic antidepressant (TCA (1)
5-HT2A partial agonist (1) ·
NMDA antagonist; fluorinated ketamine analogue (1) ·
'"`UNIQ--vote-00000019-QINU`"' Therapeutic plasma-level monitoring is standard practice for TCAs given the narrow therapeutic index and the established plasma-level-efficacy correlation. CYP2D6 substrate; CPIC PGx guidance applies for dose individualization'"`UNIQ--ref-0000001A-QINU`"'. (1)
Showing below up to 3 results in range #1 to #3.


